Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery

Cited 33 time in scopus
Metadata Downloads
Title
Implication of aberrant glycosylation in cancer and use of lectin for cancer biomarker discovery
Author(s)
Yong Sam Kim; Hyang Sook Yoo; Jeong Heon Ko
Bibliographic Citation
Protein and Peptide Letters, vol. 16, no. 5, pp. 499-507
Publication Year
2009
Abstract
Aberrant glycosylation is frequently found in cancer, and efforts for biomarker discovery include the preparation of aberrant glycoproteins as promising analytes. Several lectins that bind to aberrant glycans and can be thus used to capture and enrich aberrant glycoproteins in the frontal stage during biomarker discovery are to be introduced.
Keyword
Aberrant glycosylationbiomarkercancerlectinglycosyltransferase
ISSN
0929-8665
Publisher
Bentham Science Publ Ltd
DOI
http://dx.doi.org/10.2174/092986609788167798
Type
Article
Appears in Collections:
Synthetic Biology and Bioengineering Research Institute > Genome Editing Research Center > 1. Journal Articles
Files in This Item:
  • There are no files associated with this item.


Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.